Sun Pharma's Unloxcyt: Skin Cancer's New Superhero Unleashed

So, Sun Pharma just unveiled some seriously impressive stats about Unloxcyt, their skin cancer warrior, at the ASCO Annual Meeting in Chicago. With a dazzling 50% response rate from 64 patients, this drug is proving it’s more than just a lab coat model. No fatalities here, just a few mild bumps like anemia and diarrhea. Looks like skin cancer just met its match!